Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference45 articles.
1. Lung cancer-where are we today? Current advances in staging and nonsurgical treatment;Spiro;Am J Respir Crit Care Med,2002
2. Preoperative evaluation of patients undergoing lung resection surgery;Datta;Chest,2003
3. Molecular classification and molecular genetics of human lung cancers;Meyerson;Semin Oncol,2004
4. Rapid and sensitive p53 alteration analysis in biopsies from lung cancer patients using a functional assay and a universal oligonucleotide array: a prospective study;Fouquet;Clin Cancer Res,2004
5. Molecular signatures in biopsy specimens of lung cancer;Borczuk;Am J Respir Crit Care Med,2004
Cited by 147 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Germline EGFR mutations in lung cancer (Review);Oncology Letters;2023-05-16
2. Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR;International Journal of Cancer;2023-03-21
3. Gamma Knife Radiosurgery Irradiation of Surgical Cavity of Brain Metastases: Factor Analysis and Gene Mutations;Life;2023-01-14
4. A non-small cell lung cancer (NSCLC) patient harboring a rare epidermal growth factor receptor (EGFR) L858R/V843I mutation complex benefited from osimertinib: a case report;Annals of Palliative Medicine;2022-03
5. Correlation of EGFR G873R mutation with prognosis of docetaxel in non-small cell lung cancer;Journal of Thoracic Disease;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3